TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NIH Emerges From Republican Revolution With Another Increase in Appropriations October 4, 1996
TCL Archive Partnership Points to New Path Forward For Drug Approval and Clinical Research June 20, 2014
TCL Archive NCA Urges Switching More Funds To Grants From Contract Programs Over Entire Three Years July 2, 1976